Spots Global Cancer Trial Database for male breast carcinoma

Every month we try and update this database with for male breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	NCT00861705	Male Breast Car... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Triple-Negative...	Bevacizumab Carboplatin Cyclophosphamid... Doxorubicin Hyd... Laboratory Biom... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery	NCT00450879	Male Breast Car... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Pazopanib Hydro... Dynamic Contras... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer	NCT00070252	Adult Solid Neo... Inflammatory Br... Male Breast Car... Stage IIIA Brea... Stage IIIB Brea...	Capecitabine Docetaxel Laboratory Biom... Pharmacological... Tipifarnib	18 Years -	National Cancer Institute (NCI)
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer	NCT02206334	Male Breast Car... Prostate Adenoc... Recurrent Breas... Recurrent Non-S... Recurrent Prost... Stage IV Breast... Stage IV Non-Sm... Stage IV Prosta...	Stereotactic Bo...	18 Years -	NRG Oncology
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer	NCT00699491	Male Breast Car... Recurrent Breas... Stage IV Breast...	Cixutumumab Laboratory Biom... Pharmacological... Temsirolimus	18 Years -	National Cancer Institute (NCI)
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery	NCT00450879	Male Breast Car... Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Pazopanib Hydro... Dynamic Contras... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Access to Genetic Testing in Underserved Patients With Cancer	NCT06422455	Breast Carcinom... Male Breast Car... Malignant Solid... Metastatic Pros... Ovarian Carcino... Pancreatic Exoc... Stage IVB Prost... Triple-Negative...	Best Practice Educational Int... Electronic Heal... Genetic Counsel... Interview Survey Administ...	18 Years -	University of Southern California
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen	NCT00118157	Estrogen Recept... Male Breast Car... Progesterone Re... Recurrent Breas... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Laboratory Biom... Lapatinib Ditos... Tamoxifen Citra...	18 Years -	National Cancer Institute (NCI)
Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer	NCT01349959	Male Breast Car... Recurrent Breas... Stage IIIC Brea... Stage IV Breast... Triple-Negative...	Azacitidine Entinostat Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors	NCT01131234	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Solid Neo... Male Breast Car... Recurrent Adult... Recurrent Breas... Recurrent Colon... Recurrent Melan... Recurrent Non-S... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Stage III Pancr... Stage III Renal... Stage IIIA Colo... Stage IIIA Non-... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Skin... Stage IIIB Brea... Stage IIIB Colo... Stage IIIB Non-... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Skin... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Skin... Stage IV Breast... Stage IV Non-Sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Skin M... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Gamma-Secretase... Cediranib Malea... Pharmacological... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Access to Genetic Testing in Underserved Patients With Cancer	NCT06422455	Breast Carcinom... Male Breast Car... Malignant Solid... Metastatic Pros... Ovarian Carcino... Pancreatic Exoc... Stage IVB Prost... Triple-Negative...	Best Practice Educational Int... Electronic Heal... Genetic Counsel... Interview Survey Administ...	18 Years -	University of Southern California
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer	NCT02206334	Male Breast Car... Prostate Adenoc... Recurrent Breas... Recurrent Non-S... Recurrent Prost... Stage IV Breast... Stage IV Non-Sm... Stage IV Prosta...	Stereotactic Bo...	18 Years -	NRG Oncology
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer	NCT02206334	Male Breast Car... Prostate Adenoc... Recurrent Breas... Recurrent Non-S... Recurrent Prost... Stage IV Breast... Stage IV Non-Sm... Stage IV Prosta...	Stereotactic Bo...	18 Years -	NRG Oncology
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery	NCT00770809	Male Breast Car... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Laboratory Biom... Lapatinib Ditos... Paclitaxel Trastuzumab	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: